An AI Scientist Proposed an ADHD Treatment on the Blockchain: BIO Price Surges
Key Takeaways:
- Bio Protocol’s crypto has soared 90% following a $6.9M funding boost for its AI-native platform, Bio V2.
- The funding was led by Maelstrom Fund and aims to facilitate onchain fundraising and autonomous AI co-scientists.
- Bio Protocol’s scientific proposal for an ADHD treatment targeting orexin receptors drove excitement in crypto-science circles.
- BIO’s recent price spike of 40% from a low-liquidity range highlights volatility in DeSci investments.
- LiquidChain is developing cross-chain infrastructure to support emerging DeSci and DeFi applications.
WEEX Crypto News, 2026-04-17 07:14:58
Decentralized Science and BIO Crypto’s Surge
Bio Protocol crypto recently experienced a staggering 90% price increase, catalyzed by substantial funding advancements and innovative AI applications. With a $6.9 million financial injection from Maelstrom Fund, Bio V2—a full-stack AI-native platform—was positioned at the forefront, promising onchain fundraising capabilities and AI-driven co-scientists, known as BioAgents. This development is a significant step forward in decentralized science (DeSci), capturing the focus of traders and scientists alike.
The spotlight shone further as Bio Protocol’s scientific team proposed a peptide targeting ADHD, sparking interest across crypto-science communities. Studies have shown that ADHD patients have lower levels of orexin-A/B, key in regulating arousal and attention. While existing treatments suppress orexin activity, Bio Protocol and @peptai_ have developed a peptide labeled OX2R-004, aiming to activate the OX2R receptor—potentially redefining ADHD treatment.
Can Bio Protocol Maintain Its Bullish Momentum?
Bio Protocol’s bold 40% price surge emerged from a low-liquidity environment, typifying DeSci’s high volatility. This sudden leap, while exciting, lacked a firm technical foundation, leading to questions about whether the spike can be sustained or will retract. Such moves are often followed by a period of consolidation or a partial pullback, determined by the balance between hype-driven interests and tangible utility.
Currently, BIO finds itself at an intersection between heightened interest and practical utility. To ensure a lasting price escalation, demand must translate into real-world usage, sustaining momentum as the narrative surpasses mere speculation. However, if Bio V2 fails to deliver measurable impact, the price may revert to its pre-announcement level. The broader crypto market also plays a role; downward trends in related tokens could influence BIO, potentially triggering a broader decline.
The Role of LiquidChain in DeSci’s Growth
LiquidChain has emerged as a potential game-changer in bridging the gap between decentralized science and decentralized finance applications. It’s constructing a Layer 3 protocol that combines Bitcoin’s financial strength, Ethereum’s DeFi capabilities, and Solana’s execution speed into a single, cohesive liquidity environment, without the need for asset wrapping. This innovation is key to supporting multi-chain DeSci initiatives.
LiquidChain’s architecture enables developers to create applications once and tap into user bases across multiple ecosystems—an attractive proposition for DeSci and DeFi projects. As of now, $674,947.04 has been raised in its presale, with tokens priced at $0.0145. However, presales harbor risks; success hinges on broader adoption rates, while premature entries have diminishing returns once catalysts are publicly realized.
FAQ Section
What caused Bio Protocol’s price to surge by 90%?
Bio Protocol’s price increased due to a $6.9 million funding round for its AI-native platform, Bio V2, backed by Maelstrom Fund. This elevated efforts for onchain fundraising and the involvement of AI co-scientists, attracting significant interest.
Is Bio Protocol’s ADHD treatment scientifically promising?
Bio Protocol’s ADHD treatment focuses on activating the OX2R receptor with a peptide, OX2R-004. This contrasts current treatments which suppress orexin activity, offering a scientifically provocative approach to ADHD.
Can Bio Protocol sustain its current price level?
To maintain its price, Bio Protocol needs continuous demand linked to practical usage and proven utility of its platform. Hype alone can cause the price to revert once interest wanes.
What does LiquidChain offer to DeSci and DeFi projects?
LiquidChain facilitates a unified liquidity environment across blockchain ecosystems—Bitcoin, Ethereum, and Solana—thereby supporting DeSci and DeFi applications through its deploy-once framework without asset wrapping.
Are there risks associated with investing in LiquidChain’s presale?
LiquidChain’s presale carries risks, particularly due to adoption uncertainties. The potential for low initial market listings and reliance on sustained infrastructure integration poses investment challenges.
You may also like

a16z Crypto Partner: Cash flow is the moat

Citibank releases "2030 Asset Tokenization Market Outlook": 6 major trends may create a $8.2 trillion market

The trillion-dollar valuation test: Are the three major super IPOs a celebration for tech stocks or a nightmare for the crypto market?

Morning Report | Digital Asset completes $355 million financing led by a16z Crypto; Meta completes operational separation from Manus

Morning News | CME Group launches Nasdaq Cryptocurrency Index futures; Asset management giant Janus Henderson strategically invests in Ethena

Bitcoin Layer 2 Network Botanix: Why Did We Choose to Dissolve?

Why did Oracle deliver the strongest financial report in history, yet its stock price fell?

When the P2P illicit funds from ten years ago turned into 60,000 bitcoins

Dialogue with OmenX Founder: Why does the prediction market need an evolution from "spot" to "derivatives"?

Galaxy in-depth report: Is Solana still worth paying attention to?

Young people in South Korea make a "final effort" in the epic bull market

The pricing controversy of Trade.xyz exposes the fatal weakness of Pre-IPO perpetual contracts

How much longer can Ethereum's last big buyer hold on?

World Cup 2026 Coming – WEEX Celebrates with $1M Prize Pool & Michael Owen Live

Morning Report | OpenAI has submitted an S-1 registration statement draft to the U.S. SEC; Morpho completes $175 million financing

Galaxy Deep Research Report: How Hyperliquid's HIP-4 Upgrade Changes the Landscape of Prediction Markets?

Latest research from 13 top universities including Cornell University: The current state, challenges, and misconceptions of the fusion of Crypto and AI


